Gastric Mixed Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2014-08-04
Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial results for the Akt inhibitor MK-2206 in advanced gastric and gastroesophageal junction cancers have been posted.